ImmunoGen, Inc. (IMGN)
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company’s product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
ImmunoGen, Inc. (IMGN)‘s Financial Overview
ImmunoGen, Inc. (IMGN) declined -2.45% yesterday to close its trading session at $10.74. The company has 1 year Price Target of $12. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 4.63 Million shares yesterday. The firm shows the market capitalization of $1.43 Billion.
The firm is trading with SMA20 of -8.25 Percent, SMA50 of SMA50 Percent and SMA200 of 45.71 percent. ImmunoGen, Inc. has P/S value of 12.42. Similarly, the company has Return on Assets of -44.4 percent, Return on Equity of 81.7 percent and Return on Investment of 371 Percent.
The Stock currently has Analyst’ mean Recommendation of 2.1 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 8 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 11.50, with a high estimate of 18.00 and a low estimate of 3.00. The median estimate represents a +7.08% increase from the last price of 10.74.
Hecla Mining Co. (HL)
Hecla Mining Company is a leading low-cost U.S. silver producer with operating mines in Alaska and Idaho, and is a growing gold producer with an operating mine in Quebec, Canada. The Company also has exploration and pre-development properties in five world-class silver and gold mining districts in the U.S., Canada, and Mexico, and an exploration office and investments in early-stage silver exploration projects in Canada.
Hecla Mining Co. (HL)’s Financial Outlook
The 11 analysts offering 12-month price forecasts for Hecla Mining Co have a median target of 5.00, with a high estimate of 8.50 and a low estimate of 4.10. The median estimate represents a +38.89% increase from the last price of 3.60.
According to Zacks Investment Research, Hecla Mining Co. has a Consensus Recommendation of 2.25. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged0.84% and closed its last trading session at $3.6. The company has the market capitalization of $1.44 Billion. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 4.63 Million shares. The company has a total of 399.15 Million shares outstanding.
The company has YTD performance of -9.32 percent. Beta for Hecla Mining Co. stands at 0.41 while its ATR (average true range) is 0.16. The company has Weekly Volatility of 3.24%% and Monthly Volatility of 4.18%.
Hecla Mining Co. has distance from 20-day Simple Moving Average (SMA20) of -3.28%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of -20.45%.
The Company currently has ROA (Return on Assets) of -1 percent, Return on Equity (ROE) of -1.6 Percent and Return on Investment (ROI) of 0.7% with Gross margin of 27.2 percent and Operating & Profit margin of 11.2% and -4.2% respectively.